HSBC Holdings’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-454,149
Closed -$83.5M 2728
2021
Q2
$83.5M Sell
454,149
-181,762
-29% -$33.4M 0.09% 186
2021
Q1
$97.6M Buy
635,911
+262,234
+70% +$40.3M 0.11% 140
2020
Q4
$58.3M Buy
373,677
+89,581
+32% +$14M 0.08% 227
2020
Q3
$32.4M Sell
284,096
-16,438
-5% -$1.88M 0.05% 292
2020
Q2
$33.7M Sell
300,534
-30,661
-9% -$3.44M 0.06% 250
2020
Q1
$29.6M Buy
331,195
+130,981
+65% +$11.7M 0.07% 242
2019
Q4
$21.5M Sell
200,214
-157,494
-44% -$16.9M 0.04% 391
2019
Q3
$35M Buy
357,708
+220,629
+161% +$21.6M 0.07% 246
2019
Q2
$18M Sell
137,079
-5,264
-4% -$689K 0.03% 407
2019
Q1
$19.2M Sell
142,343
-10,945
-7% -$1.48M 0.04% 395
2018
Q4
$14.9M Buy
153,288
+11,784
+8% +$1.15M 0.03% 439
2018
Q3
$19.7M Buy
141,504
+5,672
+4% +$788K 0.03% 418
2018
Q2
$16.9M Sell
135,832
-47,835
-26% -$5.94M 0.03% 432
2018
Q1
$20.5M Sell
183,667
-99,396
-35% -$11.1M 0.03% 441
2017
Q4
$33.9M Sell
283,063
-47,995
-14% -$5.74M 0.05% 351
2017
Q3
$46.4M Buy
331,058
+152,217
+85% +$21.4M 0.07% 216
2017
Q2
$21.8M Buy
178,841
+41,381
+30% +$5.03M 0.04% 379
2017
Q1
$16.7M Buy
137,460
+13,001
+10% +$1.58M 0.03% 418
2016
Q4
$15.2M Buy
124,459
+14,920
+14% +$1.83M 0.04% 423
2016
Q3
$13.4M Buy
109,539
+8,765
+9% +$1.07M 0.03% 439
2016
Q2
$11.8M Sell
100,774
-5,453
-5% -$637K 0.03% 475
2016
Q1
$14.8M Sell
106,227
-4,714
-4% -$656K 0.04% 420
2015
Q4
$21.2M Sell
110,941
-12,376
-10% -$2.36M 0.05% 338
2015
Q3
$19.3M Sell
123,317
-148,047
-55% -$23.2M 0.05% 382
2015
Q2
$49.1M Sell
271,364
-27,435
-9% -$4.96M 0.1% 200
2015
Q1
$51.8M Buy
298,799
+52,488
+21% +$9.1M 0.1% 196
2014
Q4
$45.6M Buy
246,311
+43,131
+21% +$7.98M 0.09% 197
2014
Q3
$33.7M Buy
203,180
+6,385
+3% +$1.06M 0.07% 241
2014
Q2
$30.8M Buy
196,795
+14,981
+8% +$2.34M 0.07% 268
2014
Q1
$27.6M Sell
181,814
-24,571
-12% -$3.73M 0.07% 279
2013
Q4
$27.4M Sell
206,385
-4,580
-2% -$609K 0.07% 257
2013
Q3
$24.5M Buy
210,965
+157,112
+292% +$18.3M 0.07% 279
2013
Q2
$4.97M Buy
+53,853
New +$4.97M 0.02% 598